Period2 Dec 2022

Media coverage

1

Media coverage

  • TitleExperimental Alzheimer's Drug Lecanemab May Slow Decline, But Safety Concerns Linger
    Media name/outletIndian Pharma Industry : Policies
    Country/TerritoryIndia
    Date2/12/22
    PersonsSamuel Gandy